Iswari Setianingsih
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Iswari Setianingsih has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Alida Harahap
Eijkman Institute for Molecular Biology
2 shared publications- Alida Roswita Harahap
Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta 10430, Indonesia
2 shared publications - Ita Margaretha Nainggolan
Eijkman Research Center for Molecular Biology , National Research and Innovation Agency , Jalan Raya Bogor Km. 46 Cibinong, Bogor 16911 , Indonesia , brin.go.id
2 shared publications Alida R. Harahap
The Eijkman Institute for Molecular Biology JakartaIndonesia; Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia JakartaIndonesia
1 shared publicationApriliina Kartikasari
1 shared publicationDasril Daud
Department of Child Health, Dr. Wahidin Suryohusodo Hospital, Faculty of Medicine, University of Hasanudin, Ujung Pandang, Indonesia
1 shared publication
Latest Publications
- Open Access
- 10 September 2018
- Published by MDPI AG in Pharmaceuticals
- Vol. 11 (3) , 85
Iron Absorption in Iron-Deficient Women, Who Received 65 mg Fe with an Indonesian Breakfast, Is Much Better from NaFe(III)EDTA than from Fe(II)SO4, with an Acceptable Increase of Plasma NTBI. A Randomized Clinical Trial
Plasma non-transferrin-bound iron (NTBI) is potentially harmful due to the generation of free radicals that cause tissue damage in vascular and other diseases. Studies in iron-replete and iron-deficient subjects, receiving a single oral test dose of Fe(II)SO4 or NaFe(III)EDTA with water, revealed that FeSO4 was well absorbed when compared with NaFeEDTA, while only the Fe(II) compound showed a remarkable increase of NTBI. As NaFeEDTA is successfully used for food fortification, a double-blind randomized cross-over trial was conducted in 11 healthy women with uncomplicated iron deficiency. All subjects received a placebo, 6.5 mg FeSO4, 65 mg FeSO4, 6.5 mg NaFeEDTA, and 65 mg NaFeEDTA with a traditional Indonesian breakfast in one-week intervals. Blood tests were carried out every 60 min for five hours. NTBI detection was performed using the fluorescein-labeled apotransferrin method. Plasma iron values were highly increased after 65 mg NaFeEDTA, twice as high as after FeSO4. A similar pattern was seen for NTBI. After 6.5 mg of NaFeEDTA and FeSO4, NTBI was hardly detectable. NaFeEDTA was highly effective for the treatment of iron deficiency if given with a meal, inhibiting the formation of nonabsorbable Fe-complexes, while NTBI did not exceed the range of normal values for iron-replete subjects.
- 10 September 2018
- Published by MDPI AG in Pharmaceuticals
- Vol. 11 (3) , 85
Open AccessIron Absorption in Iron-Deficient Women, Who Received 65 mg Fe with an Indonesian Breakfast, Is Much Better from NaFe(III)EDTA than from Fe(II)SO4, with an Acceptable Increase of Plasma NTBI. A Randomized Clinical Trial
Plasma non-transferrin-bound iron (NTBI) is potentially harmful due to the generation of free radicals that cause tissue damage in vascular and other diseases. Studies in iron-replete and iron-deficient subjects, receiving a single oral test dose of Fe(II)SO4 or NaFe(III)EDTA with water, revealed that FeSO4 was well absorbed when compared with NaFeEDTA, while only the Fe(II) compound showed a remarkable increase of NTBI. As NaFeEDTA is successfully used for food fortification, a double-blind randomized cross-over trial was conducted in 11 healthy women with uncomplicated iron deficiency. All subjects received a placebo, 6.5 mg FeSO4, 65 mg FeSO4, 6.5 mg NaFeEDTA, and 65 mg NaFeEDTA with a traditional Indonesian breakfast in one-week intervals. Blood tests were carried out every 60 min for five hours. NTBI detection was performed using the fluorescein-labeled apotransferrin method. Plasma iron values were highly increased after 65 mg NaFeEDTA, twice as high as after FeSO4. A similar pattern was seen for NTBI. After 6.5 mg of NaFeEDTA and FeSO4, NTBI was hardly detectable. NaFeEDTA was highly effective for the treatment of iron deficiency if given with a meal, inhibiting the formation of nonabsorbable Fe-complexes, while NTBI did not exceed the range of normal values for iron-replete subjects.
- Open Access
- 18 December 2013
- Published by Taylor & Francis in Hemoglobin
- Vol. 38 (2) , 149-151
Severe α-Thalassemia Intermedia Due to a Compound Heterozygosity for the Highly Unstable Hb Adana (HBA2: c.179G>A) and a Novel Codon 24 (HBA2: c.75T>A) Mutation
We report a novel mutation at codon 24 of the α2-globin gene (HBA2: c.75T > A) found in a Sundanese family. This novel mutation was detected during prenatal diagnosis. The couple already had a 7-year-old boy who exhibited clinically severe α-thalassemia intermedia (α-TI), and he was found to be a compound heterozygote for the novel mutation at codon 24 and the previously described Hb Adana (HBA2: c.179G > A) at codon 59 of the α2-globin gene. The father was a carrier of the novel point mutation and showed normal hemoglobin (Hb) and a low mean corpuscular volume (MCV) and mean corpuscular Hb (MCH) value.
- 18 December 2013
- Published by Taylor & Francis in Hemoglobin
- Vol. 38 (2) , 149-151
Open AccessSevere α-Thalassemia Intermedia Due to a Compound Heterozygosity for the Highly Unstable Hb Adana (HBA2: c.179G>A) and a Novel Codon 24 (HBA2: c.75T>A) Mutation
We report a novel mutation at codon 24 of the α2-globin gene (HBA2: c.75T > A) found in a Sundanese family. This novel mutation was detected during prenatal diagnosis. The couple already had a 7-year-old boy who exhibited clinically severe α-thalassemia intermedia (α-TI), and he was found to be a compound heterozygote for the novel mutation at codon 24 and the previously described Hb Adana (HBA2: c.179G > A) at codon 59 of the α2-globin gene. The father was a carrier of the novel point mutation and showed normal hemoglobin (Hb) and a low mean corpuscular volume (MCV) and mean corpuscular Hb (MCH) value.
- 1 January 2003
- Published by Springer Nature
- Vol. 531, 47-56
Alpha Thalassaemia in Indonesia: Phenotypes and Molecular Defects
- 1 January 2003
- Published by Springer Nature
- Vol. 531, 47-56
Alpha Thalassaemia in Indonesia: Phenotypes and Molecular Defects
- Open Access
- 31 August 1999
- Published by Wiley in American Journal of Hematology
- Vol. 62 (1) , 7-12
Phenotypic variability of Filipino β°‐thalassemia/HbE patients in Indonesia
- 31 August 1999
- Published by Wiley in American Journal of Hematology
- Vol. 62 (1) , 7-12
Open AccessPhenotypic variability of Filipino β°‐thalassemia/HbE patients in Indonesia